Tenofovir amibufenamide

DB18805InvestigationalSmall molecule

Tenofovir amibufenamide: Overview.

Mechanism: Pharmacologically active on Reverse transcriptase/RNaseH and Reverse transcriptase
Curator reviewed
Formula / weight: C₂₂H₃₁N₆O₅P · 490.501 g/mol (avg)
Code names: HS-10234

Resolves to

Compound

Structure

InChIKeyORHSFGJQGPUCRR-JTJFVBHCSA-NSMILESCC(C)OC(=O)C(C)(C)N[P@@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tenofovir amibufenamide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.